Clinical trial
Lenalidomide Maintenance in Plasma Cell Myeloma
NCT02538198 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lenalidomide Maintenance in Plasma Cell Myeloma
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 31, 2015
- Completion date
- August 31, 2027
- Enrollment
- 108 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
plasma cell myeloma